Dr Stephen Falk: Clinical oncology
Search

Dr Stephen Falk

Clinical oncology

 

  • Fee assured
Overview

Specialises in

  • Colon
  • Lower GI
  • Skin
  • Upper GI

About me

Stephen qualified from Liverpool University in 1983 and spent a period in Liverpool undertaking a general medical rotation. He then trained in oncology in Cardiff and Cambridge becoming a consultant in Bristol in 1994.





He has sessional commitments to Southmead Hospital Bristol and attends the Taunton Nuffield hospital. His major clinical interest is gastro-intestinal cancer (oesophagus, stomach, pancreas, colo-rectal). A further interest in lung cancer and clinical research was stimulated as a MRC Clinical Scientist in Norman Bleehens’ unit in Cambridge where the MRC cancer trials unit was situated at the time. A MD related to lung cancer and scheduling of topoisomerase poisons with and without radiation is the basis of on-going interest in chemo-radiation interactions. He has a major interest in research and where possible all patients who are referred will be offered an appropriate clinical trial.




Unitl recently a challenging clinical load has seen up to 1000 new patients with cancer annually, but now is spending more time as clinical lead for the trials unit within the Bristol Haematology and Oncology centre and for the National Cancer Research Network locally in Avon Somerset and Wiltshire. Stephen is Clinical director of the Western Comprehensive Local Research network whose job is to fund the NHS costs of delivering research activity in the NHS. He is also a member of the NCRI upper GI studies group, and chairs the pancreatic sub group


He is a member of the editorial board of the journal Clinical Oncology, and an author in more than 50 publications and has recently written a book aimed at patients and their families with lung cancer: Lung Cancer: The facts, published in November 2009 and endorsed by the Roy Castle Foundation







More details of Lung Cancer: The facts can be found at:

http://ukcatalogue.oup.com/product/9780199569335.do?keyword=lung+cancer&sortby=bestMatches





More details of the National cancer research network can be found at http://www.ncrn.org.uk/







More details of the Western Comprehensive local research network can be found at

http://www.ukcrn.org.uk/index/networks/comprehensive/clrns/western.html









Areas of interest

Gastro-intestinal oncology; Colorectal (bowel) cancer; Lung cancer; Pancreatic cancer; Oesophageal cancer

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0002

    Clinical supervision and planning for delivery of chemotherapy cycle 1 - 14 days - (5-50)

    Spire Bristol Hospital (1-5)

  • AA844

    Clinical supervision and planning for delivery of chemotherapy cycle in the member's home 1-28 days - (5-50)

  • AA843

    Clinical supervision and planning for delivery of chemotherapy cycle in the member's home 1-21 days - (5-50)

  • X0003

    Clinical supervision and planning for delivery of chemotherapy cycle 1 - 21 days - (5-50)

    Spire Bristol Hospital (1-5)

  • X0007

    Clinical supervision of external beam radiotherapy, up to and including 15 fractions or part thereof - (1-5)

    Bristol Haematology and Oncology Centre (1-5)

  • X0004

    Clinical supervision and planning for delivery of chemotherapy cycle 1 - 28 days - (1-5)

  • X6950

    Clinical supervision of the planning of stereotactic radiosurgery e.g. SRT/SBRT and Gamma Knife - (1-5)

    Bristol Haematology and Oncology Centre (1-5)

  • Show All (9)...
Edit details Print page

The information contained on Finder is submitted by consultants, therapists and facilities, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the data and information on Finder and our website terms of use here.